HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today ...

Abstract: A generalized framework to subspace-based direction-of-arrival (DOA) estimation in the presence of unknown noise field and other imperfections is proposed. Provided the noise covariance ...

Efgartigimod significantly improves MG-ADL and QMG scores in generalized myasthenia gravis, with early responses linked to shorter disease duration and severe bulbar symptoms. Early responders often ...

Treatment with cemdisiran was associated with a statistically significant improvement in MG-ADL total score compared with placebo. Topline results were announced from a phase 3 trial evaluating ...

Stay up-to-date on President Trump and national politics Wednesday as Trump and first lady Melania meet with King Charles III, who’s rolling out the red carpet for Trump and has invited him to a State ...

CLEVELAND — Researchers narrowed down what appears to be the correct dosage during a first ever rigorous clinical trial examining LSD as a treatment for generalized anxiety disorder, with results ...

Cardiff Metropolitan University provides funding as a member of The Conversation UK. Nepal’s prime minister, KP Sharma Oli, resigned on September 9 as his country reeled from some of its worst unrest ...

Abstract: Generalized visual grounding tasks, including Generalized Referring Expression Comprehension (GREC) and Segmentation (GRES), extend the classical visual grounding paradigm by accommodating ...

A rigorous new study finds that a single dose of LSD can ease anxiety and depression for months. The study involved 198 adults with generalized anxiety disorder, or GAD, a disabling form of anxiety ...

Atlas, the humanoid robot famous for its parkour and dance routines, has recently begun demonstrating something altogether more subtle but also a lot more significant: It has learned to both walk and ...

Regeneron has reported a phase 3 win in generalized myasthenia gravis (gMG), positioning the pharma to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular ...